Homoeopathy as an add-on in treatment of COVID-19

Effectiveness of Individualized homoeopathy as an add-on to standard treatment of COVID-19 - A multicentric, randomized, parallel arm, single blind, placebo, controlled study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026195

Enrollment

300

Registered

2020-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Homoeopathic medicine along with standard care: Homoeopathic medicines will be given to this group patients as an add-on to standard treatmet. Following Individualization medicines will

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hospitalized symptomatic patients with COVID-19 infection 2. Age between 18 years to 80 years 3. Both the sexes 4. Willing to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases 2. Patients on ventilatory support 3. Immunocompromised patients 4. Subjects considered to be unable to complete the study, or not suitable for the study by researchers. 5. Women during pregnancy. 6. Lactating mothers

Design outcomes

Primary

Measure	Time frame
Clinical recovery of patient or requirement of life support (ventilator)/ death.Timepoint: Ever 24 hr.	—

Secondary

Measure	Time frame
1. Time to fever clearance 2. Change in severity of symptoms as per clinical syndromes associated with COVID - 19 infection. 3. Time to resolution of pneumonia 4. Time to recovery 5. Period of hospital stay 6. Requirement of conventional medication till clinical improvement Timepoint: Ever 24 hr.	—

Countries

India

Contacts

Public ContactDr Anupriya

CCRH

anil23101961@gmail.com09911127619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026